The University of Newcastle, Researcher report.

Researcher: Ms Danielle Lang
School: School of Medicine and Public Health
Commenced with Institution: 16-FEB-1998
Personal URL:

Funded Projects

Please note, only grants administered through the University of Newcastle Research Office are recorded here. For a more complete picture of the researcher's grant history a Personal URL may be supplied, above.

Research Team Initial Year Duration (Years) Funding Body/Client Award Type Title of Project Collaborating Partners Total Cash $ Total Inkind $
Ms Danielle Lang 2004 1 University of Newcastle Travel - Travel Grant 2nd International Conference on Improving Use of Medicines (ICIUM2004), 30 March - 2 April 2004, Thailand   1066  
Conjoint A/Prof Dianne O'Connell;Ms Danielle Lang;Ms B Pekarsky 2000 1 Hunter Urban Division of General Practice Project - Research Grant Local evaluation of the after hours primary medical care trial at Maitland Hospital.   42952  

Research Publications

Please note, the publications listed here:
(1) relate to the researcher's position at the University of Newcastle only
(2) are for selected categories of publications, and
(3) relate to publication year 1998, onwards.
For a more complete picture of the researcher's publication history a Personal URL may be supplied at the top of this page.

Journal Article

Salkeld G, Henry David Alexander, Hill Suzanne Rose, Lang Danielle Leigh, Freemantle N, D'Assuncao J, ’What drives health-care spending priorities? An international survey of health-care professionals’, Plos Medicine, 4 256-259 (2007) [C1]

Henry David Alexander, Lang Danielle Leigh, ’Published pharmacoeconomic analyses: science or marketing?’, Internal Medicine Journal, 33 404-404 (2003) [C4]

Robertson Jane, Lang Danielle Leigh, Hill Suzanne Rose, ’Use of pharmacoeconomics in prescribing research. Part 1: costs - moving beyond the acquisition price for drugs’, Journal of Clinical Pharmacy and Therapeutics, 28 73-79 (2003) [C1]

Lopert Ruth, Lang Danielle Leigh, Hill Suzanne Rose, ’Use of pharmacoeconomics in prescribing research. Part 3: cost-effectiveness analysis - a technique for decision-making at the margin’, Journal of Clinical Pharmacy and Therapeutics, 28 243-249 (2003) [C1]

Lopert Ruth, Lang Danielle Leigh, Hill Suzanne Rose, Henry David Alexander, ’Differential pricing of drugs: a role for cost-effectiveness analysis?’, The Lancet, 359 2105-2107 (2002) [C1]

Whitworth J, Lang Danielle Leigh, Henry David Alexander, ’Cost-effectiveness Analysis in the Treatment of Hypertension: A Medical View’, Clinical and Experimental Hypertension, 21(5-6) 999-1008 (1999) [C1]

Return to Search page